Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-089666
Filing Date
2025-06-24
Accepted
2025-06-24 19:06:41
Documents
1
Period of Report
2025-06-20

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5854
  Complete submission text file 0000950170-25-089666.txt   7459
Mailing Address C/O MOORE CORPORATION LIMITED ONE CANTERBURY GREEN STAMFORD CT 06901
Business Address
DANIELS RONALD J (Reporting) CIK: 0001164475 (see all company filings)

State of Incorp.: A6 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 251070502

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)